Roche's Accutane Warning Passes Muster In MDL

Law360, New York (July 24, 2012, 7:01 PM EDT) -- Hoffmann-La Roche Inc. adequately warned an Accutane user about the risk of developing inflammatory bowel disease while on the acne drug, a Florida federal judge overseeing multidistrict litigation ruled Tuesday, a decision that could affect much larger Accutane litigation in New Jersey.

The ruling brings an end to one of the few remaining suits in the federal multidistrict litigation over the drug, which was cut down by U.S. District Judge James S. Moody Jr.'s June 2007 decision to exclude the general causation testimony of an expert...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Accutane Products Liability


Case Number

8:04-md-02523

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

James S. Moody, Jr

Date Filed

November 18, 2004

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.